These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 1832302

  • 1. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
    Maier W, Rosenberg R, Argyle N, Buller R, Roth M, Brandon S, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(1):22-30. PubMed ID: 1832302
    [Abstract] [Full Text] [Related]

  • 2. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
    Albus M, Lecrubier Y, Maier W, Buller R, Rosenberg R, Hippius H.
    Acta Psychiatr Scand; 1990 Nov; 82(5):359-65. PubMed ID: 2281806
    [Abstract] [Full Text] [Related]

  • 3. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
    Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R, DuPont RL.
    Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
    [Abstract] [Full Text] [Related]

  • 4. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
    Maier W, Roth SM, Argyle N, Buller R, Lavori P, Brandon S, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 May; 241(3):151-8. PubMed ID: 1790160
    [Abstract] [Full Text] [Related]

  • 5. Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
    Klerman GL.
    J Psychiatr Res; 1990 May; 24 Suppl 2():27-41. PubMed ID: 1980697
    [Abstract] [Full Text] [Related]

  • 6. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
    Rosenberg R, Bech P, Mellergård M, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991 May; 365():39-45. PubMed ID: 1862733
    [Abstract] [Full Text] [Related]

  • 7. A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine.
    Mellergård M, Lorentzen K, Bech P, Ottosson JO, Rosenberg R.
    Acta Psychiatr Scand Suppl; 1991 May; 365():28-32. PubMed ID: 1862731
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
    Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS.
    J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
    [Abstract] [Full Text] [Related]

  • 9. Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
    Rosenberg R, Bech P, Mellergård M, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991 Apr; 365():46-52. PubMed ID: 1862734
    [Abstract] [Full Text] [Related]

  • 10. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    Charney DS, Woods SW, Goodman WK, Rifkin B, Kinch M, Aiken B, Quadrino LM, Heninger GR.
    J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
    [Abstract] [Full Text] [Related]

  • 11. Alprazolam in the treatment of panic attack patients with and without major depression.
    Pyke RE, Kraus M.
    J Clin Psychiatry; 1988 Feb; 49(2):66-8. PubMed ID: 3338978
    [Abstract] [Full Text] [Related]

  • 12. Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborative Panic Study.
    Buller R, Maier W, Goldenberg IM, Lavori PW, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 Feb; 240(3):163-8. PubMed ID: 1827602
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
    Andersch S, Rosenberg NK, Kullingsjö H, Ottosson JO, Bech P, Bruun-Hansen J, Hanson L, Lorentzen K, Mellergård M, Rasmussen S.
    Acta Psychiatr Scand Suppl; 1991 Feb; 365():18-27. PubMed ID: 1862730
    [Abstract] [Full Text] [Related]

  • 14. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo.
    Pollack MH, Otto MW, Sachs GS, Leon A, Shear MK, Deltito JA, Keller MB, Rosenbaum JF.
    J Affect Disord; 1994 Apr; 30(4):273-81. PubMed ID: 8014326
    [Abstract] [Full Text] [Related]

  • 15. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Schweizer E, Rickels K, Weiss S, Zavodnick S.
    Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
    [Abstract] [Full Text] [Related]

  • 16. A meta-analysis of treatments for panic disorder with agoraphobia: imipramine, alprazolam, and in vivo exposure.
    Cox BJ, Endler NS, Lee PS, Swinson RP.
    J Behav Ther Exp Psychiatry; 1992 Sep; 23(3):175-82. PubMed ID: 1487535
    [Abstract] [Full Text] [Related]

  • 17. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
    Deltito JA, Argyle N, Klerman GL.
    J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
    [Abstract] [Full Text] [Related]

  • 18. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment.
    Lesser IM, Rubin RT, Rifkin A, Swinson RP, Ballenger JC, Burrows GD, Dupont RL, Noyes R, Pecknold JC.
    J Affect Disord; 1989 Mar; 16(1):49-58. PubMed ID: 2521651
    [Abstract] [Full Text] [Related]

  • 19. Successful use of clonazepam in patients with treatment-resistant panic disorder.
    Tesar GE, Rosenbaum JF.
    J Nerv Ment Dis; 1986 Aug; 174(8):477-82. PubMed ID: 3734770
    [Abstract] [Full Text] [Related]

  • 20. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
    Munjack DJ, Crocker B, Cabe D, Brown R, Usigli R, Zulueta A, McManus M, McDowell D, Palmer R, Leonard M.
    J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.